Skip to main content
NCBI home page
Gut logoLink to Gut
. 1996 Aug;39(2):267–272. doi: 10.1136/gut.39.2.267

Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying.

J M Nightingale 1, M A Kamm 1, J R van der Sijp 1, M A Ghatei 1, S R Bloom 1, J E Lennard-Jones 1
PMCID: PMC1383310  PMID: 8977342

Abstract

BACKGROUND: Short bowel patients with a jejunostomy have large volume stomal outputs, which may in part be due to rapid gastric emptying of liquid. Short bowel patients with a preserved colon do not have such a high stool output and gastric emptying of liquid is normal. AIMS: To determine if differences in the gastric emptying rate between short bowel patients with and without a colon can be related to gastrointestinal hormone changes after a meal. SUBJECTS: Seven short bowel patients with no remaining colon (jejunal length 30-160 cm) and six with jejunum in continuity with a colon (jejunal length 25-75 cm), and 12 normal subjects. METHODS: The subjects all consumed a 640 kcal meal; blood samples were taken for 180 minutes for measurement of gastrointestinal hormones. RESULTS: Patients with a colon had high fasting peptide YY values (median 71 pmol/l with a colon; 11 pmol/l normal subjects, p < 0.005) with a normal postprandial rise, but those without a colon had a low fasting (median 7 pmol/l, p = 0.076) and a reduced postprandial peptide YY response (p < 0.050). Motilin values were high in some patients without a colon. In both patient groups fasting and postprandial gastrin and cholecystokinin values were high while neurotensin values were low. There were no differences between patient groups and normal subjects in enteroglucagon, pancreatic polypeptide, or somatostatin values. CONCLUSIONS: Low peptide YY values in short bowel patients without a colon may cause rapid gastric emptying of liquid. High values of peptide YY in short bowel patients with a retained colon may slow gastric emptying of liquid and contribute to the "colonic brake'.

Full text

PDF
267

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adrian T. E., Ballantyne G. H., Longo W. E., Bilchik A. J., Graham S., Basson M. D., Tierney R. P., Modlin I. M. Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon. Gut. 1993 Sep;34(9):1219–1224. doi: 10.1136/gut.34.9.1219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adrian T. E., Ferri G. L., Bacarese-Hamilton A. J., Fuessl H. S., Polak J. M., Bloom S. R. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology. 1985 Nov;89(5):1070–1077. doi: 10.1016/0016-5085(85)90211-2. [DOI] [PubMed] [Google Scholar]
  3. Adrian T. E., Long R. G., Fuessl H. S., Bloom S. R. Plasma peptide YY (PYY) in dumping syndrome. Dig Dis Sci. 1985 Dec;30(12):1145–1148. doi: 10.1007/BF01314048. [DOI] [PubMed] [Google Scholar]
  4. Adrian T. E., Savage A. P., Bacarese-Hamilton A. J., Wolfe K., Besterman H. S., Bloom S. R. Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology. 1986 Feb;90(2):379–384. doi: 10.1016/0016-5085(86)90936-4. [DOI] [PubMed] [Google Scholar]
  5. Adrian T. E., Savage A. P., Fuessl H. S., Wolfe K., Besterman H. S., Bloom S. R. Release of peptide YY (PYY) after resection of small bowel, colon, or pancreas in man. Surgery. 1987 Jun;101(6):715–719. [PubMed] [Google Scholar]
  6. Adrian T. E., Savage A. P., Sagor G. R., Allen J. M., Bacarese-Hamilton A. J., Tatemoto K., Polak J. M., Bloom S. R. Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology. 1985 Sep;89(3):494–499. doi: 10.1016/0016-5085(85)90442-1. [DOI] [PubMed] [Google Scholar]
  7. Ali-Rachedi A., Varndell I. M., Adrian T. E., Gapp D. A., Van Noorden S., Bloom S. R., Polak J. M. Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas. Histochemistry. 1984;80(5):487–491. doi: 10.1007/BF00495439. [DOI] [PubMed] [Google Scholar]
  8. Allen J. M., Fitzpatrick M. L., Yeats J. C., Darcy K., Adrian T. E., Bloom S. R. Effects of peptide YY and neuropeptide Y on gastric emptying in man. Digestion. 1984;30(4):255–262. doi: 10.1159/000199117. [DOI] [PubMed] [Google Scholar]
  9. Andrews N. J., Irving M. H. Human gut hormone profiles in patients with short bowel syndrome. Dig Dis Sci. 1992 May;37(5):729–732. doi: 10.1007/BF01296430. [DOI] [PubMed] [Google Scholar]
  10. Aponte G. W., Fink A. S., Meyer J. H., Tatemoto K., Taylor I. L. Regional distribution and release of peptide YY with fatty acids of different chain length. Am J Physiol. 1985 Dec;249(6 Pt 1):G745–G750. doi: 10.1152/ajpgi.1985.249.6.G745. [DOI] [PubMed] [Google Scholar]
  11. Baak L. C., Jansen J. B., Biemond I., Lamers C. B. Weekend treatment with 20 and 40 mg omeprazole: effect on intragastric pH, fasting and postprandial serum gastrin, and serum pepsinogens. Gut. 1991 Sep;32(9):977–982. doi: 10.1136/gut.32.9.977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Becker H. D., Reeder D. D., Thompson J. C. Extraction of circulating endogenous gastrin by the small bowel. Gastroenterology. 1973 Dec;65(6):903–906. [PubMed] [Google Scholar]
  13. Bilchik A. J., Hines O. J., Adrian T. E., McFadden D. W., Berger J. J., Zinner M. J., Ashley S. W. Peptide YY is a physiological regulator of water and electrolyte absorption in the canine small bowel in vivo. Gastroenterology. 1993 Nov;105(5):1441–1448. doi: 10.1016/0016-5085(93)90149-7. [DOI] [PubMed] [Google Scholar]
  14. Blackburn A. M., Fletcher D. R., Bloom S. R., Christofides N. D., Long R. G., Fitzpatrick M. L., Baron J. H. Effect of neurotensin on gastric function in man. Lancet. 1980 May 10;1(8176):987–989. doi: 10.1016/s0140-6736(80)91434-8. [DOI] [PubMed] [Google Scholar]
  15. Bloom S. R. An enteroglucagon tumour. Gut. 1972 Jul;13(7):520–523. doi: 10.1136/gut.13.7.520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bloom S. R., Polak J. M. Somatostatin. Br Med J (Clin Res Ed) 1987 Aug 1;295(6593):288–290. doi: 10.1136/bmj.295.6593.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Bryant M. G., Bloom S. R. Distribution of the gut hormones in the primate intestinal tract. Gut. 1979 Aug;20(8):653–659. doi: 10.1136/gut.20.8.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Buxton B. Small bowel resection and gastric acid hypersecretion. Gut. 1974 Mar;15(3):229–238. doi: 10.1136/gut.15.3.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Böttcher G., Sjölund K., Ekblad E., Håkanson R., Schwartz T. W., Sundler F. Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut. Regul Pept. 1984 Jul;8(4):261–266. doi: 10.1016/0167-0115(84)90034-x. [DOI] [PubMed] [Google Scholar]
  20. Christofides N. D., Long R. G., Fitzpatrick M. L., McGregor G. P., Bloom S. R. Effect of motilin on the gastric emptying of glucose and fat in humans. Gastroenterology. 1981 Mar;80(3):456–460. [PubMed] [Google Scholar]
  21. Christofides N. D., Modlin I. M., Fitzpatrick M. L., Bloom S. R. Effect of motilin on the rate of gastric emptying and gut hormone release during breakfast. Gastroenterology. 1979 May;76(5 Pt 1):903–907. [PubMed] [Google Scholar]
  22. Debas H. T., Yamagishi T., Dryburgh J. R. Motilin enhances gastric emptying of liquids in dogs. Gastroenterology. 1977 Oct;73(4 Pt 1):777–780. [PubMed] [Google Scholar]
  23. Dowling R. H., Booth C. C. Functional compensation after small-bowel resection in man. Demonstration by direct measurement. Lancet. 1966 Jul 16;2(7455):146–147. doi: 10.1016/s0140-6736(66)92426-3. [DOI] [PubMed] [Google Scholar]
  24. Gleeson M. H., Bloom S. R., Polak J. M., Henry K., Dowling R. H. Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut. 1971 Oct;12(10):773–782. doi: 10.1136/gut.12.10.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Jansen J. B., Lamers C. B. Radioimmunoassay of cholecystokinin in human tissue and plasma. Clin Chim Acta. 1983 Jul 15;131(3):305–316. doi: 10.1016/0009-8981(83)90100-6. [DOI] [PubMed] [Google Scholar]
  26. Kennedy H. J., Sarson D. L., Bloom S. R., Truelove S. C. Gut hormone responses in subjects with a permanent ileostomy. Digestion. 1982;24(2):133–136. doi: 10.1159/000198788. [DOI] [PubMed] [Google Scholar]
  27. Lieverse R. J., Jansen J. B., Masclee A. M., Lamers C. B. Satiety effects of cholecystokinin in humans. Gastroenterology. 1994 Jun;106(6):1451–1454. doi: 10.1016/0016-5085(94)90397-2. [DOI] [PubMed] [Google Scholar]
  28. Miazza B. M., Al-Mukhtar M. Y., Salmeron M., Ghatei M. A., Felce-Dachez M., Filali A., Villet R., Wright N. A., Bloom S. R., Crambaud J. C. Hyperenteroglucagonaemia and small intestinal mucosal growth after colonic perfusion of glucose in rats. Gut. 1985 May;26(5):518–524. doi: 10.1136/gut.26.5.518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Muurahainen N., Kissileff H. R., Derogatis A. J., Pi-Sunyer F. X. Effects of cholecystokinin-octapeptide (CCK-8) on food intake and gastric emptying in man. Physiol Behav. 1988;44(4-5):645–649. doi: 10.1016/0031-9384(88)90330-7. [DOI] [PubMed] [Google Scholar]
  30. Nightingale J. M., Bartram C. I., Lennard-Jones J. E. Length of residual small bowel after partial resection: correlation between radiographic and surgical measurements. Gastrointest Radiol. 1991 Fall;16(4):305–306. doi: 10.1007/BF01887374. [DOI] [PubMed] [Google Scholar]
  31. Nightingale J. M., Kamm M. A., van der Sijp J. R., Morris G. P., Walker E. R., Mather S. J., Britton K. E., Lennard-Jones J. E. Disturbed gastric emptying in the short bowel syndrome. Evidence for a 'colonic brake'. Gut. 1993 Sep;34(9):1171–1176. doi: 10.1136/gut.34.9.1171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Nightingale J. M., Lennard-Jones J. E., Gertner D. J., Wood S. R., Bartram C. I. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut. 1992 Nov;33(11):1493–1497. doi: 10.1136/gut.33.11.1493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Nightingale J. M., Lennard-Jones J. E., Walker E. R., Farthing M. J. Jejunal efflux in short bowel syndrome. Lancet. 1990 Sep 29;336(8718):765–768. doi: 10.1016/0140-6736(90)93238-k. [DOI] [PubMed] [Google Scholar]
  34. Nightingale J. M., Walker E. R., Burnham W. R., Farthing M. J., Lennard-Jones J. E. Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Aliment Pharmacol Ther. 1989 Aug;3(4):367–373. doi: 10.1111/j.1365-2036.1989.tb00223.x. [DOI] [PubMed] [Google Scholar]
  35. PORUS R. L. EPITHELIAL HYPERPLASIA FOLLOWING MASSIVE SMALL BOWEL RESECTION IN MAN. Gastroenterology. 1965 Jun;48:753–757. [PubMed] [Google Scholar]
  36. Polak J. M., Buchan A. M. Motilin. Immunocytochemical localization indicates possible molecular heterogeneity or the existence of a motilin family. Gastroenterology. 1979 May;76(5 Pt 1):1065–1066. [PubMed] [Google Scholar]
  37. Polak J. M., Sullivan S. N., Bloom S. R., Buchan A. M., Facer P., Brown M. R., Pearse A. G. Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry. Nature. 1977 Nov 10;270(5633):183–184. doi: 10.1038/270183a0. [DOI] [PubMed] [Google Scholar]
  38. Roberts C. J. Clinical pharmacokinetics of ranitidine. Clin Pharmacokinet. 1984 May-Jun;9(3):211–221. doi: 10.2165/00003088-198409030-00003. [DOI] [PubMed] [Google Scholar]
  39. Rudo N. D., Rosenberg I. H. Chronic glucagon administration enhances intestinal transport in the rat. Proc Soc Exp Biol Med. 1973 Feb;142(2):521–525. doi: 10.3181/00379727-142-37059. [DOI] [PubMed] [Google Scholar]
  40. Savage A. P., Adrian T. E., Carolan G., Chatterjee V. K., Bloom S. R. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut. 1987 Feb;28(2):166–170. doi: 10.1136/gut.28.2.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Spiller R. C., Trotman I. F., Adrian T. E., Bloom S. R., Misiewicz J. J., Silk D. B. Further characterisation of the 'ileal brake' reflex in man--effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. Gut. 1988 Aug;29(8):1042–1051. doi: 10.1136/gut.29.8.1042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Straus E., Gerson C. D., Yalow R. S. Hypersecretion of gastrin associated with the short bowel syndrome. Gastroenterology. 1974 Feb;66(2):175–180. [PubMed] [Google Scholar]
  43. Sturdevant R. A., Goetz H. Cholecystokinin both stimulates and inhibits human food intake. Nature. 1976 Jun 24;261(5562):713–715. doi: 10.1038/261713a0. [DOI] [PubMed] [Google Scholar]
  44. Temperley J. M., Stagg B. H., Wyllie J. H. Disappearance of gastrin and pentagastrin in the portal circulation. Gut. 1971 May;12(5):372–376. doi: 10.1136/gut.12.5.372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Weinstein L. D., Shoemaker C. P., Hersh T., Wright H. K. Enhanced intestinal absorption after small bowel resection in man. Arch Surg. 1969 Nov;99(5):560–562. doi: 10.1001/archsurg.1969.01340170012003. [DOI] [PubMed] [Google Scholar]
  46. Williams N. S., Evans P., King R. F. Gastric acid secretion and gastrin production in the short bowel syndrome. Gut. 1985 Sep;26(9):914–919. doi: 10.1136/gut.26.9.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Windsor C. W., Fejfar J., Woodward D. A. Gastric secretion after massive small bowel resection. Gut. 1969 Oct;10(10):779–786. doi: 10.1136/gut.10.10.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. de Miguel E., Gómez de Segura I. A., Bonet H., Rodríguez Montes J. A., Mata A. Trophic effects of neurotensin in massive bowel resection in the rat. Dig Dis Sci. 1994 Jan;39(1):59–64. doi: 10.1007/BF02090061. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES